Nicole Vitullo, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 13,435 shares at $5.22 ($70K) on 2013-03-20, disclosed to the SEC on 2013-03-21.
Scheduled sale ($70k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.19 | 7,925 | $41K | 58.8% |
| 2 | $5.22 | 5,510 | $29K | 41.2% |
| Total | $5.20 avg | 13,435 | $70K | 100% |
| Filing → |
| ESPR | SELL | 2018-01-26 | $1.7M | — | Filing → |
| ESPR | SELL | 2017-12-08 | $502K | — | Filing → |
| CLCD | SELL | 2016-05-02 | $2.1M | — | Filing → |